Another FDA win for Reverse Medical with IDE nod for Barrel vascular device

Reverse Medical wins FDA approval to launch U.S. clinical trials of its Barrel vascular reconstruction device for use in treating aneurysms.

California-based Reverse Medical landed key FDA approval to launch U.S. clinical trials of its Barrel vascular reconstruction device for treatment of intracranial bifurcation aneurysms.

The company plans to finalize its trial structure "very soon" and begin enrolling patients within the next few months, president & CEO Jeffrey Valko said in prepared remarks.

Food & Drug Administration (FDA), Reverse Medical Corp.

News Well, Investigational Device Exemption (IDE), Regulatory/Clearance, Food & Drug Administration (FDA), Vascular

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1imhb8O